Furthermore, the unique pathophysiology of end-stage liver disease (ESLD) has important implications on critical care treatment after transplantation [9] . Although liver transplantation has been the sole treatment of patients with ESLD for over 20 years, only limited data are available addressing the intensive care management and complications of this patient population [10, 11] .